se of citrate content dialysate in patients on hemodialysis

Phase 4

Recruiting

• Conditions: Chronic kidney disease; N18.0

• Registration Number: RBR-2z9xyb
• Lead Sponsor: Divisão de Nefrologia da Faculdade de Medicina da Universidade Federal Fluminense

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-02-13
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients older than 18 years of age, both genders, on maintenance hemodialysis, without major comorbidities.

Exclusion Criteria

Prescription of hemodialysis shorter than 3h 30 min.
Use of oral anticoagulant.
Use of temporary double lumen catheter.
Awating for living donor kidney transplant.
Refuse to participate.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
oss of the dialyzer before 12th use due to clotting of blood in the extracorporeal circuit or reduction of fiber bundle volume >20% of baseline.

Secondary Outcome Measures

Name	Time	Method
Reduction of hemodialysis efficiency assessed by the urea Kt/V at 1st, 6th and 12th dialysis sessions of each phase.<br><br>Incidence of hypocalcemia or hypomagnesemia in each phase of the study.<br>